Dysregulated Tyrosine Kinase Signaling in Leukemia

University of New Mexico (UNM)

Status: Terminated

Conditions: Leukemia

Study type: Observational

Funder types: Other

Identifiers

NCT00277056

1602C

Details and patient eligibility

About

Dysregulated Tyrosine Kinase Signaling in Leukemia

Full description

Purpose: to look at a number of proteins in the abnormal cells in the blood and/or bone marrow. These proteins make a cell grow or prevent the cell from dying

Enrollment: 30 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients must have newly diagnosed or relapsed leukemia.
• Patients must sign an informed consent.
• Patients will not be excluded if they are receiving chemotherapy.
• Patients with CML, AML, ALL, T/NK leukemia, myelodysplasia, or myeloproliferative disorders will be eligible.
• Patients must be => 18 years of age.